DrugPatentWatch Database Preview
Drugs in Development Information for Beloranib
Email this page to a colleague
» See Plans and PricingWhat is the development status for investigational drug Beloranib?
Beloranib is an investigational drug.
There have been 8 clinical trials for Beloranib.
The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2014.
The most common disease conditions in clinical trials are Overweight, Obesity, and Syndrome. The leading clinical trial sponsors are Zafgen, Inc. and [disabled in preview].
There are five US patents protecting this investigational drug and twenty-five international patents.
Summary for Beloranib
| US Patents | 5 |
| International Patents | 25 |
| US Patent Applications | 9 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2014-09-01) |
| Vendors | 10 |
Recent Clinical Trials for Beloranib
| Title | Sponsor | Phase |
|---|---|---|
| An Efficacy and Safety Study of Beloranib in Obese Subjects With Type 2 Diabetes Mellitus | Zafgen, Inc. | Phase 2 |
| Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome | Zafgen, Inc. | Phase 3 |
| An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury | Zafgen, Inc. | Phase 2 |
Clinical Trial Summary for Beloranib
Top disease conditions for Beloranib
Top clinical trial sponsors for Beloranib
US Patents for Beloranib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Beloranib | Start Trial | Fumigillol compounds and methods of making and using same | Zafgen, Inc. (Boston, MA) | Start Trial |
| Beloranib | Start Trial | Methods of treating a subject with benign prostate hyperplasia | Zafgen, Inc. (Cambridge, MA) | Start Trial |
| Beloranib | Start Trial | Fumigillol compounds and methods of making and using same | Zafgen, Inc. (Boston, MA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Beloranib
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Beloranib | Australia | 2013259620 | 2032-05-09 | Start Trial |
| Beloranib | Brazil | 112014027981 | 2032-05-09 | Start Trial |
| Beloranib | Canada | 2873574 | 2032-05-09 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
